| __timestamp | BeiGene, Ltd. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6930000 | 72429000 |
| Thursday, January 1, 2015 | 7311000 | 78634000 |
| Friday, January 1, 2016 | 20097000 | 75374000 |
| Sunday, January 1, 2017 | 62602000 | 92157000 |
| Monday, January 1, 2018 | 195385000 | 93326000 |
| Tuesday, January 1, 2019 | 388249000 | 103132000 |
| Wednesday, January 1, 2020 | 600176000 | 110171000 |
| Friday, January 1, 2021 | 990123000 | 218817000 |
| Saturday, January 1, 2022 | 1277852000 | 233827000 |
| Sunday, January 1, 2023 | 1504501000 | 267194000 |
Igniting the spark of knowledge
In the competitive landscape of the pharmaceutical and healthcare sectors, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. BeiGene, Ltd. and Lantheus Holdings, Inc. offer a fascinating study in contrasts. Over the past decade, BeiGene's SG&A expenses have skyrocketed, increasing by over 21,500% from 2014 to 2023. This reflects their aggressive expansion strategy and investment in global operations. In contrast, Lantheus Holdings has maintained a more stable trajectory, with SG&A costs rising by approximately 270% over the same period. This suggests a more controlled growth approach, focusing on efficiency and cost management. As investors and industry analysts look to the future, the question remains: will BeiGene's high-spending strategy yield long-term returns, or will Lantheus's steady approach prove more sustainable?
Novo Nordisk A/S or Lantheus Holdings, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and BeiGene, Ltd.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights